Idexx Laboratories has launched a total T4 dry-slide test, giving veterinary surgeons real-time access to additional chemistry information.
The new test is compatible with all the company’s in-clinic laboratory analysers.
Simon Wootton, UK Marketing Manager from Idexx says that it is important for vets to be able to update a patient’s chemistry during a visit: “Conditions like hyper- or hypothyroidism require intervention and careful long-term monitoring. It is also important to assess the possible effects on other relevant medical parameters. This is why vets often want to update a patient’s chemistry data during the clinic visit. To accommodate this need, accurate and dependable chemistry, electrolyte and T4 test results can now be delivered in as little as 15 minutes.
“By adding thyroid screening to diagnostic protocols – which may already include fructosamine, phenobarbital, and urine P:C testing – practices can now get comprehensive chemistry, electrolyte and T4 measurements from a single sample, in a single run. This will let vets detect abnormalities sooner and respond more effectively.”
For more information, visit: https://www.idexx.com
Merial has published figures which show that gutworm is seriously affecting dairy cow fertility in up to 80% of UK dairy herds1, in order to raise awareness of the damaging impact of Ostertagia ostertagi.
Sioned Timothy, veterinary adviser for Merial said: “The reduction in milk production from a gutworm infection is well documented2. Both animal health advisers (Suitably Qualified Persons – SQPs) and vets recognise the threat such infections cause. However, since cows often show no outward signs of disease, even in the face of a massive challenge, dairy farmers could unwittingly suffer heavy losses in milk yield, reduced fertility and increased heifer rearing costs at a time when they can least afford it.”
Merial points out that the extent of a herd’s gutworm exposure can be easily and simply assessed from a sample taken from the bulk milk tank – using the MOO Test. This test determines the amount of antibody to Osteragia ostertagi present in a sample, giving an assessment of the level of herd gutworm challenge.
The metabolic demands placed on cows during the post-calving period can lead to a negative energy balance, when energy gained from feed intake is less than that used for milk production. This natural ‘energy gap’ leads to weight loss; a parasite burden can make matters worse.
Sioned advises taking action to reduce the effect of this post-calving energy gap to maintain productivity levels. She said: “Management of cows in the weeks following calving should focus on maximising dry matter intake to correct the energy imbalance as quickly as possible. Studies have shown that cows treated for gutworm have improved appetites, and graze for up to an hour longer than untreated cows3. Grass is the cheapest form of nutrition so it makes sense to make the most of it.”
Merial also points towards studies which have shown that effective parasite control may have a beneficial effect4,5. Reduced body condition scores caused by the energy gap after calving may impact on reproductive parameters. In one study, cows treated for gutworm were back in calf 13 days sooner than untreated animals4.
Sioned said: "This has obvious implications for productivity. We need to look at employing a range of practical measures to ensure cows are as productive and efficient as possible, and this includes targeted worming where required.”
According to the company, effective parasite management of the replacement heifer during the rearing period is key to her future performance and productivity. Achieving breed-appropriate target weights throughout the rearing period is a crucial component of heifer rearing. The onset of puberty and the start of breeding are more closely linked to weight, body size and condition score than age. It is therefore critical to ensure that heifers reach approximately 60% of mature weight by 14 months of age in order to achieve a 24 month average age at calving.
Sioned said: “Losses in potential liveweight gain due to poor parasite control during a heifer’s first grazing season will not be recouped during the second year at grass6. She won’t catch up, and this will impact on her ability to meet important milestones.”
Getting heifers in-calf at the optimal time will help to reduce breeding costs and maximises the potential productive life of the animal. Heifers treated for gutworm have been shown to have a 20% higher conception rate at first service than untreated cattle2.
Merial says there is also evidence that parasite burdens exert physiological effects that directly impact on the parameters influencing performance and profitability of heifers, and increased mammary development and earlier onset of puberty have been observed in strategically wormed heifers in comparison to those left untreated7,8.
Sioned said: “Effective worming will mitigate the effect of parasites on fertility levels in growing cattle4, while still allowing them to build the necessary immunity required to prevent clinical disease in adulthood.”
References
The RCVS Disciplinary Committee has restored a veterinary surgeon who had previously been convicted of fraud to the Register, after finding him fit to resume practising.
Matthew Morgan had pleaded guilty to four counts of fraud in July 2013 having fraudulently claimed over £200,000 in pet insurance claims between November 2009 and December 2012. In August 2013 he was sentenced to two years’ imprisonment, for which he served 12 months and was then released on licence.
Following his conviction and sentence, his case was brought to the RCVS Disciplinary Committee in February 2014 where it was decided to strike him off the Register. When his licence period expired on 18 August 2015, Mr Morgan applied for restoration to the Register.
During the course of the hearing, the Disciplinary Committee heard evidence from Mr Morgan, who accepted the findings of the Committee, describing the evidence as ‘fair’ and acknowledging the seriousness of his actions.
The Committee felt that Mr Morgan’s criminal conduct was very grave, as reflected in his custodial sentence and the fact that, as an Australian citizen, he had been issued with a deportation notice by the Home Office. It also felt that his crime had struck at the heart of public confidence in a profession for which honesty and integrity is expected.
However, the Committee considered that Mr Morgan, if restored, would pose few risks in respect of protection of the public, having no concerns about his competence as a veterinary surgeon, and accepted that there was little future risk to animal welfare if he were to be restored.
The Committee also considered that, since his release from prison, Mr Morgan has taken extensive steps to rehabilitate himself, has undertaken continuing professional development and has been working as a veterinary care assistant at two veterinary practices to keep up-to-date with current practice.
Furthermore, the Committee was satisfied that there was public support for Mr Morgan continuing as a veterinary surgeon given the references and testimonials submitted on his behalf.
In coming to its conclusion the Disciplinary Committee reiterated the seriousness of Mr Morgan’s criminal offending, saying that it had caused it “the greatest concern”. However, it also felt that issues of rehabilitation needed to be considered.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: “The Committee cannot emphasise enough the fact that veterinary surgeons who commit acts of fraud in the exercise of their practice can expect severe consequences, both in the criminal courts and within their own College and there can be no doubt that the decision to remove the applicant from the Register was a proper reflection of the seriousness of his offending.
“Given all of the matters referred to above, however, the Committee considers that the applicant has demonstrated sufficiently that he has learned the lessons required and is now fit to be restored to the Register.”
Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.
According to the company, compliance with daily ear drops has been shown to be poor, with up to 80% of owners administering the incorrect dose to their pet. The most common reason for a lack of compliance is the difficultly in applying the drops1.
Elanco says that Osurnia has the potential to improve compliance in treating otitis externa significantly, because unlike other medications which require 5-28 doses during the course of treatment2, Osurnia only needs two-doses given a week apart.
Osurnia contains a gel formulation of three active ingredients including the antibiotic florfenicol, which is new to companion animal treatment in the UK, terbinafine, which inhibits the growth of yeast as demonstrated for Malassezia spp., and the glucocorticosteroid, betamethasone acetate, to help relieve discomfort.
Osurnia is administered in a pre-measured, single-dose tube designed to ensure the right dose every time. It has a flexible, soft tip designed to make treatment with Osurnia a comfortable experience for the dog. The gel formulation squeezes out of the tube and spreads through the ear, adhering inside the ear canal for long-lasting action. The dose is the same for any dog, regardless of size and weight.
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health said: “Otitis externa is a common challenge for both vets and clients, with ear infections among the ten most frequent reasons for dogs to be presented with vets, affecting up to 20% of dogs3.
“Osurnia is an innovative, effective treatment that is administered in just two doses ensuring it is much more convenient for pet owners thereby increasing the likelihood that they will complete the entire treatment schedule leading to more comfortable dogs and peace of mind for owners.”
Elanco has produced a client leaflet on treating otitis externa with Osurnia. For further information, or to order client leaflets, please contact your local Elanco Animal Health Territory Manager or email elancoCAH.uk@elanco.com.
Virbac has launched Cooldent, described as a highly palatable, fast-acting tablet to freshen dogs' breath.
Claire Lewis, Product Manager, explained: "Bad breath in dogs is unpleasant and is most frequently caused by a build-up of plaque and calculus on their teeth.
"Cooldent's natural ingredients have an anti-plaque action and help both to maintain a balanced intestinal flora and to reduce gas production. They also help to freshen dogs’ mouths by contributing to the reduction of volatile compounds, produced by bacteria which can cause halitosis."
She added: "We are delighted to add Cooldent to our comprehensive dental range, alongside our VeggieDent, natural, all-vegetable, highly palatable teeth-cleaning chews for dogs and Vet Aquadent, an easy-to-use drinking water additive which helps to fight dental plaque and tartar formation in dogs and cats."
The RCVS has asked 6,700 veterinary surgeons to submit their CPD records for 2012-2014 as part of its second annual CPD audit.
The news came at more or less the same time that VetSurgeon.org announced that it is developing a new feature to make it easy for veterinary surgeons to document time they spend on the website towards their CPD requirement.
Under the RCVS Code of Professional Conduct for Veterinary Surgeons, members of the profession must undertake at least 105 hours of CPD over a rolling three-year period, averaging 35 hours per year.
Those being audited include 5,568 vets who failed to confirm whether or not they complied with the CPD requirement in this year’s annual renewal process; 488 vets who failed to respond to last year’s audit and did not confirm their compliance this year; 43 pre-2012 graduates who have not yet completed the Professional Development Phase; and 184 veterinary surgeons who specifically declared they were not compliant during this year’s annual renewal process.
In addition to these, a random sample of 400 veterinary surgeons who did declare they were compliant this year will be asked to share their records.
For last year’s audit, the College wrote to 3,975 veterinary surgeons, of whom 82% were found to be compliant. However, 910 veterinary surgeons did not respond to the request at all.
Gordon Hockey, RCVS Registrar, said: “The purpose of the exercise is not only to gauge levels of compliance, but also to gain a greater understanding of why some people are unable to meet the requirement. Therefore, we will be asking those who are still non-compliant to provide us with an explanation as to why, and to submit a learning and development plan outlining the steps they will take to become compliant.
“Since 2012, the Code of Professional Conduct has made it very clear that, as professionals, veterinary surgeons have an obligation to maintain and improve their skills and experience so as to provide a better service to their patients and clients.
“Last year’s audit proved that the majority of the profession do take CPD seriously and do engage with it over-and-above what is required, but a small minority do not. It is important to remind this small minority that persistent failure to comply with CPD requirements, or to respond to requests from the College, may result in them being reported to the Preliminary Investigation Committee.”
Christine Warman, Head of Education at the RCVS, added: “This audit is also an opportunity to remind people that we are not prescriptive when it comes to CPD and that it is not the case that we only count attendance at courses as learning and development.
“Broadly, any activities that you undertake to further your competence and provide tangible learning that can be put to use in your professional life, can be classed as CPD. For example, this could include private reading, webinars, clinical audit activities, mentoring, work-based observation and many more activities besides.
“What we ask is that you record and document these activities, reflecting on what you learnt and how it will affect your practice.”
Veterinary surgeons who are being asked to submit their records can do so by allowing the RCVS to access their online Professional Development Record (PDR) or to send in their CPD record card via email or post. The deadline for responding is Friday 13 November.
Those who wish to sign up to the free, online PDR can do so by visiting www.rcvs-pdr.org.uk. More information about what constitutes CPD and the Code of Professional Conduct requirements can be found at www.rcvs.org.uk/cpd.
Zoetis has announced that PropoFlo Plus is now back in stock following a huge surge in demand caused by supply issues with a competitor propofol.
Licensed for use in dogs and cats, PropoFlo Plus is an anaesthetic injection for the induction and maintenance of general anaesthesia for up to 20 minutes. It is used for dental treatment, biopsies, radiographs, mass removals and endoscopy.
Ned Flaxman, companion animal business unit director at Zoetis said: “Following an unprecedented demand for PropoFlo Plus, which we believe was caused by an out of stock situation from a competitor product, we have quickly ramped up production in order to return PropoFlo Plus to the market as quickly as possible. I am pleased to confirm that we now have sufficient stocks to supply the entire UK veterinary market for the foreseeable future”.
For further information, contact your Zoetis Account Manager.
Ceva Animal Health has launched Hepaticare, a new liver support supplement for cats and dogs.
The company says Hepaticare contains the same high quality ingredients as Hepatosyl, but is now enhanced with micro-encapsulated SAMe to enhance product stability and patient acceptance.
Hepaticare contains the antioxidants of S-adenosylmethionine (SAMe), vitamin E and silybin to help maintain liver function, and vitamin K to support the normal blood clotting process. Ceva says these ingredients help neutralise damaging free radicals produced by the liver during times of stress, while the SAMe has been micro-encapsulated to enhance stability, reduce any bitter aftertaste and increase patient acceptance.
Hepaticare capsules can be given whole or opened and sprinkled onto, or mixed with, food.
Rob McLintock, companion animal business unit manager at Ceva Animal Health, said: “Following a change in supplier we have taken the opportunity to launch a new liver support supplement, ensuring that the new and improved product, Hepaticare, is as effective and as easy to administer as possible.”
Hepaticare pack sizes and pricing will remain the same as for Ceva’s Hepatosyl. Until the end of September, Hepaticare will be available on a buy one get one free offer.
For further information, contact your local Ceva territory manager or phone 01494 781510.
CarefreeCredit, the loan company set up by Somerset vet Stewart Halperin so that practices can offer their clients interest free loans to cover emergency veterinary treatment, has embarked on a national PR campaign to raise awareness amongst pet owners about the service.
First out of the stalls was the Sunday Express, which covered the story last weekend. Further coverage is expected in other national newspapers over the coming few weeks.
CarefreeCredit provides loans from £250 to £25,000 for use against any veterinary bills. Credit terms offered by CarefreeCredit-enrolled veterinary practices, of which there are now more than 700, are normally 0% over 12 months or 9.9% over 24 months.
Practices pay £10 per month to enrol with CarefreeCredit, plus a small percentage of the amount of each loan made.
Stewart said: “Most vets usually end up discounting their invoices to enable pets to receive the treatment they desperately need when their owners aren’t insured and can’t afford to pay a large bill all at once. With CarefreeCredit, the owner doesn’t have to worry about paying the bill, the pet gets the treatment it needs and the vet is paid immediately and doesn’t have to worry about bad debts. Experience with this type of finance in the US shows that the average vet can reduce his debtors by up to 60%, improving his cash flow, while increasing his turnover by up to 22% per annum, so everyone’s a winner!”
For further information about offering CarefreeCredit to your clients, visit: http://www.carefreecredit.co.uk.
International Cat Care has announced the winners of four new ‘Easy to Give’ awards and three ‘Cat Friendly’ awards.
The Easy to Give award was created to reward pharmaceutical companies whose products are easy to administer to cats. Previous examples have included drugs in a highly palatable form, smaller tablets, longer lasting preparations or those with an easier mode of administration.
Easy to Give winners this year are Virbac's Prinovox (ectoparasiticide), Norbrook's Loxicom (NSAID), and Ceva's Vectra Felis (ectoparasticide) and Zodon (antibiotic).
These latest winners bring the total number of Easy to Give awards presented, since their inception in 2005, to 35.
International Cat Care CEO, Claire Bessant, said: ‘It is so important that cats receive treatments prescribed for them, whether it is for preventive care or to treat a problem. If a drug is too difficult to get into the cat, owners often fail to complete the course, leaving the cat inadequately treated – as we worry about antibiotic resistance, this is particularly important beyond the individual animal too. Struggling with a cat to medicate can put a tension into the owner/cat relationship at a time when owners feel they want to be more supportive rather than seen as something to fear. This year we asked those trying the products if the act of medication had a negative effect on their relationship with their cat, as many people find that in the struggle to medicate, often the cat becomes fearful or aggressive towards them which owners also find very distressing. This kind of innovation by pharmaceutical companies is essential to feline health.’
Easy to Give awards are confined to prescription only medicines (POMs) or methods of delivering POMs. International Cat Care also recognises other products which have made a difference to cat wellbeing and welfare, with its Cat Friendly Awards.
The Cat Friendly Awards go to the SoftE Smart Collar from MDC, the SureFeed Microchip Pet Feeder from SureFlap and the Cat Carrier Tree from Royal Canin.
For more details on the work of the charity go to www.icatcare.org.
Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle1.
In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with 41% in 2013.
According to Dr Tim Potter MRCVS from Westpoint Veterinary Group, Mycoplasma bovis has emerged as an important pathogen of calves worldwide2. He said: "It is associated with a number of clinical presentations including respiratory disease, otitis media and arthritis.
"The role of Mycoplasma bovis in pneumonia is well established and there are a number of reports in the literature of respiratory disease outbreaks where it was the predominant bacterium isolated. However, as with most causes of pneumonia, colonisation by Mycoplasma bovis alone is not always sufficient to cause disease and it may present in combination with other respiratory pathogens."
For other pathogens, the surveillance found 83% of samples positive for Para-influenza 3 virus (Pi3v), 76% Bovine Respiratory Syncytial virus (BRSv), 32% IBR, and 25% for BVD. Apart from BVD, which saw a three-point reduction from 28% the previous year - these show little change from 2013.
According to Zoetis vet Carolyn Hogan, in pneumonia outbreaks involving Mycoplasma bovis, many of the clinical signs are similar to those caused by other pneumonia pathogens: coughing, raised temperature, rapid breathing and lethargy.
She said: "This can make it difficult for farmers and vets alike to identify Mycoplasma bovis as a possible cause of disease based on clinical signs alone, unless calves are also showing some of the other distinguishing signs associated with Mycoplasma infection.
"These include ear infections, head shaking or tilting, and arthritis. Poor response to treatment, with resulting chronic respiratory cases, may also be suggestive of Mycoplasma infection. For a definitive diagnosis, of course, analysis of blood or respiratory tract mucous is required."
Whilst vaccination protection is available against the viruses (BRSv, Pi3v, BVD and IBR) and Mannheimia (Pasteurella) haemolytica, Carolyn points out that there is no ‘off the shelf’ vaccine available for Mycoplasma bovis. She adds that treatment can be challenging due to the insidious nature of disease, and lack of effectiveness of some antibiotics.
Once Mycoplasma bovis is present on a farm, Carolyn cautions that eradication can be very difficult. "It can be transmitted in milk from carrier cows, and in saliva among calves, particularly when multiple animals suckle the same teat feeders.
"Minimising this pathogen's impact on health and productivity relies on reducing its exposure to susceptible animals and maximising their resilience against it. For a comprehensive programme of control measures, farmers should consult their vet."
Carolyn suggests that such a programme is likely to include: testing the farm's Mycoplasma bovis status; effective biosecurity; not feeding infected milk; ample ventilation for adults and youngstock alike; rapid spotting of sick animals, isolation and vet-prescribed treatment; vigilance for poor response to treatment and development of chronic cases; vaccination against main viral pneumonia pathogens; and low stress through good stockmanship.
Photo: By Y tambe (Y tambe's file) [GFDL, CC-BY-SA-3.0 or CC BY-SA 2.5-2.0-1.0], via Wikimedia Commons
Bayer Animal Health has announced the launch of three new educational videos which look at some common concerns in the profession about antimicrobials, including owner compliance, laboratory testing, and prescribing policies in different clinical scenarios.
The videos follow research conducted by Bayer as part of its Veraflox What Lies Beneath campaign in which 73% of veterinary surgeons cited owner compliance as a frequent cause of treatment failure when tackling bacterial infections, and only 5%1 of vets said that they send samples for culture and sensitivity testing routinely in cases where they suspect bacterial involvement.
In the first video presentation, Matt Jones, Microbiology Manager at IDEXX Laboratories, focuses on the importance of culture and sensitivity testing, and how to interpret results from these tests. Matt discusses the merits and drawbacks of various testing techniques available, both in-house and from external laboratories.
In the second presentation, Liz Watkins, founder of Chunk Training, a veterinary training provider which specialises in customer service, provides communication tips to improve consultation technique and increase owner compliance when a course of antimicrobials has been prescribed.
In the final presentation, Ian Battersby, Recognised Specialist in Small Animal Internal Medicine at Davies Veterinary Specialists answers commonly asked questions submitted by vets about antibiotics. Questions include how to adopt a practice antimicrobial policy, how to decide when it is appropriate to use antibiotics in GI disease and how to approach cases that are not responding as expected to antimicrobial treatment.
Hannah Watts, Group Product Manager at Bayer said: ‘‘The issues highlighted by the research need to be addressed in order to help promote responsible antimicrobial use. One of the key findings from the survey was the relatively low number of culture and sensitivity tests that are routinely performed. This may in part be due to financial constraints, but in addition to assisting in appropriate antimicrobial selection, culture and sensitivity tests often save money for the client in the long run, as well as helping to resolve the condition as quickly as possible, leading to improved treatment outcomes for the pet.‘’
Watching the videos can be used to count towards your annual CPD requirement. They're now available at www.vetcentre.bayer.co.uk.
The Department for Environment, Food & Rural Affairs (Defra) has launched a consultation on reforming the governance arrangements of the RCVS.
The consultation follows a period of discussions between the RCVS and Defra about how the College might best modernise Council.
The consultation gives the public and profession the opportunity to have their say on what reforms would best prepare the College for the future. It discusses the appropriate size and composition of Council, including the proportion of elected members, how veterinary schools should be represented, increasing lay membership, and ensuring appropriate veterinary nurse representation. It also examines how flexibility can be built into the reforms in case of future changes, such as the possibility of new categories of associate. Responses to the consultation will inform the College’s work with Defra to determine the precise details of any new governance arrangements.
The College says any reform should meet its unique requirements as a Royal College that regulates and the criteria already agreed by the College: Council’s decision-making role would be strengthened, for instance, by increasing the number of Council meetings per year. This would reduce or remove the need for a separate Operational Board in order that the CEO reports directly to Council.
Any reforms also need to ensure that Council has sufficient members to populate the College’s committees and Presidential team, and follow the government’s five principles of better regulation, by being proportionate, consistent, accountable, transparent and targeted.
RCVS President Bradley Viner (pictured top right) said “I am delighted that Defra is consulting on RCVS governance and the minister has the full backing of RCVS Council in so doing. This consultation is an opportunity to hear the voice of the profession and the public about an appropriate structure and oversight of the RCVS, reflecting the uniqueness of being a Royal College that regulates. Consulting on this important issue is in keeping with our desire to become first rate in what we do, building on other measures to modernise and improve the workings of the College.”
Dr. Lauren Finka, a researcher at the University of Lincoln, has developed L-CAT, a new tool for assessing behaviour in cats at rehoming centres and help match them to the ideal new home.
During the course of her PhD studies, which were part funded by COAPE (Centre of Applied Pet Ethology), Lauren discovered inconsistencies in the current models and perceptions of behaviour traits used in re-homing cats.
For example, one of the most common behaviours associated with affection towards humans is the activity of rubbing. Initial results suggested that this is often very inconsistent, as are several other behaviours that were previously thought to to be important in assessing a cat's underlying temperament. Dr Finka’s studies showed that it all depends much more on the specifics of the physical and social context of interactions and that these may change on a daily basis. It was found that on one day a cat might rub against a person ten times, but the next day rub against the same person only once.
The Lincoln Cat Assessment Tool (L-CAT) was developed during this research. COAPE says it is the first of its kind to offer a suitably robust, reliable and easy-to-use way of assessing behaviour in cats at re-homing centres, as well in predicting new owner satisfaction based on those assessments.
The organisation goes on to say that the potential welfare implications of this research are substantial, enabling cats to be properly but rapidly assessed, optimally managed, and suitably matched with would-be owners and thus shortening the length of time cats might spend in the re-homing centre.
L-CAT was tested to establish the possibility of predicting the future behaviour of cats after they had been adopted, as well as gauging how satisfied owners were likely to be with their cats. COAPE says the results generally confirmed that these outcomes were indeed possible, meaning re-homing staff could also use L-CAT to help manage the expectations of owners and potentially improve their satisfaction.
For more information, visit: www.coape.org
The industry-led Cattle Health and Welfare Group of Great Britain (CHAWG) has published a review which identifies a practical approach to gathering antibiotic usage data on UK cattle farms.
The review outcomes, announced today at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD), highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.
But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health.
"We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms. It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.
"This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle. However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle."
Tim says that with the support of the VMD, which requested the review and will now act as secretariat, CHAWG will set up a working group to implement the report’s recommendations.
The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.
"Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.
"There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare. But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing."
Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector. In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.
Tim said: "It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works.
"Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.
CHAWG says that throughout this project, it will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible.
The CHAWG review report is available to download at www.chawg.org.uk.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Petplan has announced a new category - ‘Rising Star’ - has been added to its 2016 Veterinary Awards.
The company says its awards, which recognise members of the veterinary profession who have gone above and beyond in their daily roles, have been focussed on established individuals. The idea behind the new award is to recognise someone that is rising within their current practice, showing great aptitude and who has substantially grown in their role within a relatively short period of time.
The award is geared towards employees with less than two years’ experience, who have initiated, coordinated and accomplished a new or improved activity or process during 2015. Petplan says nominees should also show one or more of the following ‘Four C’s’ in their initiative: compassion, competence, communication and commitment.
James Barnes, Head of Sales and Partnerships at Petplan, said: “Petplan understands the importance of committed veterinary staff in ensuring pet safety and care. Working with almost 5,000 vet practices, we see the fantastic work being carried out across the country and these awards are an opportunity for pet owners to say a heartfelt ‘thank you’ for the support veterinary staff provide to the animals in their care.”
To nominate a colleague for an award, visit www.petplanvet.co.uk/vetawards before 31st January 2016.
London Vet Specialists (LVS), billed as the capital's first complete-service referral centre, has announced its official opening in Belsize Park.
The centre is headed up by senior surgeon and soft tissue specialist, Dr Janet Kovak McClaran DVM DACVS DECVS MRCVS, former head of the department of surgery at the Animal Medical Center in New York.
Janet leads a team of consultants specialising in internal medicine and surgery, diagnostic imaging, emergency and critical care, anaesthesia and analgesia, and minimally-invasive surgery.
Janet says the new centre was set up to enable London-based vets to access close-by expert help across key areas: "When I was first approached about setting up a referral centre servicing central and greater London, I was surprised that a dedicated facility didn’t already exist. Previously, referring clinicians have had to send clients on long journeys outside of the capital, leading to patient stress and hassle and extra expense for the owners. Now, they have the reassurance of access to a highly-experienced secondary and tertiary level referral team on their doorstep."
The LVS facility boasts a state-of-the-art surgical theatre, complete with a Karl Storz operating tower enabling cutting-edge laparoscopic, thoracoscopic and cystoscopic procedures. The minimally-invasive surgery suite is one of only three such facilities in the UK. An onsite CT scanner, the GE Brivio CT 385, forms part of an array of imaging equipment, operated by European Specialist in Veterinary Diagnostic Imaging, Dr Livia Benigni. The immediate interpretation of even the most-complex of images is designed to allow seamless patient investigation and negate the need for repeated patient anaesthetics.
Internal Medicine consultant Dr Kaye Gugich, formerly of Vets Now Referrals in Swindon, together with board-certified Emergency and Critical Care Specialist Dr Adam Mugford, and Dr Karla Borland, a previous resident in anaesthesia and analgesia at Edinburgh University, complete the consultant team.
London Vet Specialists says it is the only facility in central London to offer a full time specialist surgery service alongside a specialist service in emergency and critical care. Emergency stabilisation and intensive care is available around the clock, with experienced clinicians and a nursing team ensuring continuous supervision, day or night. The LVS specialist surgical team is also on call to the hospital overnight should specialist emergency surgery be required out of hours.
Patient and customer care at LVS is based on the model used by Sydney’s SASH Vets (Small Animal Specialist Hospital). LVS Client Relations Manager Claire Newton helped to develop the SASH system during her time at the advanced referral hospital, which concentrates on delivering the highest standards of patient care, alongside a dedicated support system for the client and referring vet.
Claire said: "From the very start of the referral process, customer care is prioritised. In this we consider that we have two customers; the first, the referring vet, who needs to feel that he or she has an integral role in the ongoing management of the case, and that his or her client is well-looked after. Our second customer, the pet owner or client, needs to be looked after with compassion and respect, and have the ability to speak directly to the clinician in charge of their pet, at any point. Excellent two-way communication is key. We ensure that we listen and respond to the needs of both parties through every step of the customer journey."
For more information on London Vet Specialists, or to speak to Claire Newton about referring a patient, visit www.londonvetspecialists.vet, email Claire.newton@londonvetspecialists.vet, or telephone 0207 4330155.
Merial has published Give Them Just What they Need, a guide to the key considerations concerning the vaccination of cats.
The company says it produced the guide after conducting research in which 76% of small animal veterinary surgeons said they are not fully aware of the most recent feline vaccination guidelines, and 98% said they'd find a guide useful.
The survey1, which was conducted amongst 114 UK small animal vets, also showed that whilst 82% of vets are aware of the existence of feline vaccination guidelines from organisations such as the World Small Animal Veterinary Association (WSAVA) and European Advisory Board on Cat Diseases (ABCD), 58% don’t know the content well, and a further 18% were not aware of the guidelines at all.
In a concurrent survey of 1000 cat owners2, 60% said they would have more confidence in their vet knowing that they were vaccinating according to the latest guidelines. The cat owner survey also found that 80% rely on their vet for information about vaccination, and 60% would like more information about vaccination.
Claire Edmunds, product manager at Merial, said: "Understanding that vets are busy people and using all of the insight that we have gathered from vets and owners to shape the content of the guide, we have condensed previously published vaccination recommendations from organisations such as WSAVA and ABCD into really useful, practical advice. The new guide and complementary support materials will hopefully prove to be really valuable resources for vets, giving them the information they need when reviewing their vaccination protocols, in a quick, easy-access format.
"By being better informed about the latest recommendations, we want vets to feel more confident in discussing all aspects of vaccination with their clients. With the majority of cat owners saying that they rely on their vet for vaccination information and nearly half stating that their vet clearly explaining the benefits of vaccination would increase their compliance in vaccinating their cat, this obviously will be beneficial to both the practice and pet cats."
Merial has also produced supporting materials for use alongside the guide, including a take-home leaflet for owners and digital assets for social media and newsletter use, designed to help vets start discussions about vaccination.
Give Them Just What they Need is available from your regional Merial Territory Manager or for download at https://goo.gl/7Uas3y
Boehringer Ingelheim has launched Bitesize (www.bi-bitesize.co.uk), an educational website about canine epilepsy for veterinary surgeons.
Boehringer’s Brand Manager Craig Roxburgh said: "We have teamed up with eight neurology experts working in referral centres across the UK. These experts have covered the questions most commonly encountered when managing epilepsy cases in first opinion practice, which we hope will assist vets in their epilepsy case management."
Answers to questions are delivered as short video clips of between one and three minutes, optimised for use on smartphones and tablet devices to make them available in the practice or on the move.
Craig added: "Canine epilepsy can be a complex condition to manage. We hope therefore that when cases present, Bitesize will prove a useful and handy ‘go-to’ resource for vets to access information at the time they need it."
There's a chance to win an iPad if you visit the new site before 29th February 2016.
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
Reference
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.